Literature DB >> 11359959

IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations.

I Qvarfordt1, G C Riise, B A Andersson, S Larsson.   

Abstract

BACKGROUND: Tobacco smokers have lower serum levels of IgG than non-smokers. IgG subclass deficiency is common in patients with recurrent respiratory infections. Recurrent bronchial infections are common in smokers with chronic bronchitis (CB). We have investigated whether susceptibility to recurrent exacerbations in smokers with CB is associated with altered IgG subclass levels or IgG subclass deficiency.
METHODS: Serum levels of IgG, IgA, IgM, and IgG subclasses 1-4 were determined by radial immunodiffusion in 100 subjects: 33 smokers with stable CB and recurrent exacerbations, 24 asymptomatic smokers, and 43 healthy never smokers. Systemic tobacco exposure was verified and excluded using a serum cotinine ELISA. Immunoglobulin data were log transformed to enable use of parametric statistical methods.
RESULTS: Compared with never smokers, both patients with CB and asymptomatic smokers had significantly lower levels of IgG (median 9.7 g/l (range 5.6-15.2) and 9.9 (6.1-12.1) g/l v 12.0 (6.9-18.5) g/l) and IgG2 (2.8 (0.9-5.9) g/l and 2.5 (1.0-6.3) g/l v 4.0 (1.7-10.2) g/l). The estimated ratio of median values between the patients with CB and never smokers was 0.78 (95% confidence interval (CI) 0.69 to 0.89) for IgG and 0.65 (95% CI 0.50 to 0.83) for IgG2. The corresponding ratios between asymptomatic smokers and never smokers were 0.79 (95% CI 0.69 to 0.91) and 0.60 (95% CI 0.50 to 0.83), respectively. There were no significant differences between the smoking groups.
CONCLUSIONS: Susceptibility to recurrent exacerbations in smokers with CB is not associated with lower levels of IgG subclasses than can be accounted for by smoking per se.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359959      PMCID: PMC1746070          DOI: 10.1136/thorax.56.6.445

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

2.  Serum IgG subclass concentrations in healthy subjects at different age: age normal percentile charts.

Authors:  A Plebani; A G Ugazio; M A Avanzini; P Massimi; L Zonta; V Monafo; G R Burgio
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

3.  Immunoglobulin concentrations in serum and nasal secretions in chronic obstructive pulmonary disease. A matched-pair study.

Authors:  R D Miller; G J Gleich; K P Offord; S L Dunnette
Journal:  Am Rev Respir Dis       Date:  1979-02

Review 4.  IgG subclasses--a review.

Authors:  P H Schur
Journal:  Ann Allergy       Date:  1987-02

5.  Smoking and immunoglobulin levels.

Authors:  A Gulsvik; M K Fagerhoi
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

6.  Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

Review 7.  Cigarette smoking and respiratory tract infection.

Authors:  T W Marcy; W W Merrill
Journal:  Clin Chest Med       Date:  1987-09       Impact factor: 2.878

8.  IgG subclasses in the serum and sputum from patients with bronchiectasis.

Authors:  S L Hill; J L Mitchell; D Burnett; R A Stockley
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

9.  Serum IgG subclasses in chronic and recurrent respiratory infections.

Authors:  P J Stanley; G Corbo; P J Cole
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

10.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.

Authors:  G Boman; U Bäcker; S Larsson; B Melander; L Wåhlander
Journal:  Eur J Respir Dis       Date:  1983-08
View more
  4 in total

1.  Immunoglobulin G levels before and after lung transplantation.

Authors:  Natalie H Yip; David J Lederer; Steven M Kawut; Jessie S Wilt; Frank D'Ovidio; Yuanjia Wang; Edward Dwyer; Joshua R Sonett; Selim M Arcasoy
Journal:  Am J Respir Crit Care Med       Date:  2006-01-06       Impact factor: 21.405

2.  The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD.

Authors:  Hyun Lee; Cara Kovacs; Andre Mattman; Zsuzsanna Hollander; Virginia Chen; Raymond Ng; Janice M Leung; Don D Sin
Journal:  Respir Res       Date:  2022-05-31

3.  Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.

Authors:  Fernando Sergio Leitao Filho; Seung Won Ra; Andre Mattman; Robert S Schellenberg; Gerard J Criner; Prescott G Woodruff; Stephen C Lazarus; Richard Albert; John E Connett; Meilan K Han; Fernando J Martinez; Janice M Leung; S F Paul Man; Shawn D Aaron; Robert M Reed; Don D Sin
Journal:  Respir Res       Date:  2018-02-14

4.  Hypogammaglobulinemia and Risk of Exacerbation and Mortality in Patients with COPD.

Authors:  Are M Holm; Siw L Andreassen; Vivi Lycke Christensen; Johny Kongerud; Øystein Almås; Henrik Auråen; Anne H Henriksen; Ingeborg S Aaberge; Olav Klingenberg; Tone Rustøen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.